Reactive oxygen species generation via light-activated photosensitization

Reactive oxygen species generation via light-activated photosensitization is a biochemical process whereby certain compounds—photosensitizers—produce cytotoxic reactive oxygen species (ROS) upon illumination. This process is central to photodynamic therapy, a modality for localized cell killing in cancer and infection. Photosensitizers accumulate in the target tissue, and when exposed to specific light wavelengths, they undergo an excited-state transition that results in the transfer of energy or electrons to molecular oxygen, generating ROS such as singlet oxygen and superoxide. These ROS then provoke oxidative damage, leading to cell death through necrosis, apoptosis, or autophagy[2][3]. Despite its therapeutic utility, the process is not a molecular entity (receptor, enzyme, etc.), but a mechanism; therefore, "ROS generation via light-activated photosensitization" is not strictly a druggable target and should not be considered a canonical molecular target[1][3][4]. If you are seeking information about a specific photosensitizer molecule or a protein *targeted* in a CALI (chromophore-assisted light inactivation) approach, those should be named explicitly (e.g., "Inositol 1,4,5-trisphosphate receptor", "Porphyrin", "MiniSOG"), and the query should be adjusted accordingly.

Other names

Photodynamic ROS generationLight-activated ROS formationPhotosensitizer-induced ROS productionPhotodynamic action

Upon activation with light of a specific wavelength, the photosensitizer transitions to an excited state and transfers energy or electrons to molecular oxygen, generating ROS (e.g., singlet oxygen (^1O_2), superoxide, hydroxyl radicals), which then induce cytotoxic effects[2][3][4].